Upendra Hegde

Upendra Hegde

University of Connecticut - Storrs / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4747528
person_outline Upendra Hegde's MOST POPULAR ARTICLES
1-) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro Jr, ...The Lancet 394 (10212), 1915-1928, 201913382019
2-) Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialSB Goldberg, SN Gettinger, A Mahajan, AC Chiang, RS Herbst, M Sznol, ...The lancet oncology 17 (7), 976-983, 20168942016
3-) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the …U Hegde, A Filie, RF Little, JE Janik, N Grant, SM Steinberg, K Dunleavy, ...Blood 105 (2), 496-502, 20053852005
4-) Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWH Wilson, K Dunleavy, S Pittaluga, U Hegde, N Grant, SM Steinberg, ...Journal of clinical oncology 26 (16), 2717-2724, 20084092008
5-) Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trialHM Kluger, V Chiang, A Mahajan, CR Zito, M Sznol, T Tran, SA Weiss, ...Journal of Clinical Oncology 37 (1), 52-60, 20192682019